It has been well established that device closure has, on average, prevented stroke recurrence in people who’ve had patent foramen ovale–associated stroke, but a meta-analysis has drilled down into ...

For patients with patent foramen ovale (PFO), a novel classification system that factors in high-risk PFO features has the potential to better differentiate who is most likely to benefit from ...

We postulated that cryoablation can also fuse PFO by injuring the primary and secondary septum." Although AF and PFO are both risk factors for stroke/TIA, it is difficult to determine whether PFO is ...

Global PFO Closure Device Market Size was estimated at USD 121.53 million in 2021 and is projected to reach USD 208.00 million by 2028, exhibiting a CAGR of 7.98% during the forecast period. “PFO ...

BASEL, Switzerland—In a study of Medicare fee-for-service beneficiaries older than 60 who had had an ischemic stroke, percutaneous patent foramen ovale (PFO) closure was associated with improved ...

W.L. Gore & Associates (Gore) has launched a multicenter, prospective, randomized placebo- and sham-controlled investigational study that will evaluate the safety and efficacy of transcatheter closure ...

SAN FRANCISCO, CA — Using a device designed to close the patent foramen ovale (PFO) in patients who have had a cryptogenic ischemic stroke may reduce their risk of having another stroke, suggests ...

Researchers found closure of patent foramen ovale could result in reduced monthly migraine days. Treatment with patent foramen ovale (PFO) closure could reduce the frequency of headaches and monthly ...